El banco eleva a sobreponderar la recomendación de los títulos de la farmacéutica, que ya prepara su Capital Markets Day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback